Emergingby GlyphTargeted LNPs generate CAR-T cells inside the body
Capstan and Penn researchers report in vivo CAR-T generation in Science.
Nanotechnologydoi.org
Capstan Therapeutics
StartupUS1 field
Where it works
| Technology | ||
|---|---|---|
| NanotechnologyBuilt targeted LNPs to make CAR-T cells inside the body; acquired by AbbVie in 2025. | Built targeted LNPs to make CAR-T cells inside the body; acquired by AbbVie in 2025. | sec.gov |
Events
About
- Source
- sec.gov (filing, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Oct 6, 2026
- Across Glyph
- Capstan Therapeutics on Companies
Capstan Therapeutics
Joined in Nanotechnology. Built targeted LNPs to make CAR-T cells inside the body; acquired by AbbVie in 2025.
Capstan Therapeutics
Added in Nanotechnology. Built targeted LNPs to make CAR-T cells inside the body; acquired by AbbVie in 2025.